EDPB Supports Biotech Act with Data Safeguards
The European Data Protection Board (EDPB) and the European Data Protection Supervisor (EDPS) have issued a joint opinion on the European Biotech Act proposal. While supporting the harmonization of clinical trials, they emphasize the need for specific safeguards for sensitive health data. The EDPB and EDPS call for clear rules on data access, storage, and transfer to ensure compliance with data protection principles. They also highlight the importance of transparency and individual rights in the context of biotech research and development. The opinion is intended to inform the ongoing legislative process.
Stronger data protection requested for health data in EU Biotech Act.